Gerald Quirk
General Counsel at SYROS PHARMACEUTICALS, INC.
Net worth: 212 700 $ as of 2024-03-30
Gerald Quirk active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SYROS PHARMACEUTICALS, INC. | General Counsel | - | - |
Career history of Gerald Quirk
Former positions of Gerald Quirk
| Companies | Position | Start | End |
|---|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Chief Administrative Officer | 2017-05-31 | 2022-02-28 |
| Chief Operating Officer | - | 2022-02-28 | |
| General Counsel | 2016-08-31 | 2022-02-28 | |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | General Counsel | 2015-05-31 | 2016-08-30 |
Choate, Hall & Stewart LLP
 Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Choate, Hall & Stewart LLP provides legal services. It offers services in the areas of private equity, technology, intellectual property, mergers & acquisitions, commercial litigation, and insurance & reinsurance litigation. The company was founded in 1899 and is headquartered in Boston, MA. | Corporate Officer/Principal | 2012-09-04 | 2015-04-30 |
| INFINITY PHARMACEUTICALS, INC. | Investor Relations Contact | 2006-09-20 | 2012-07-31 |
| Public Communications Contact | 2009-12-07 | 2012-07-31 | |
| General Counsel | 2006-09-20 | 2012-07-31 | |
| Corporate Secretary | 2009-03-30 | 2012-07-31 | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 1998-03-31 | 2006-08-31 |
| Palmer & Dodge LLP | Corporate Officer/Principal | - | - |
Training of Gerald Quirk
| Harvard University | Graduate Degree |
| Swarthmore College | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Statistics
International
| United States | 10 |
Operational
| General Counsel | 4 |
| Corporate Officer/Principal | 3 |
| Graduate Degree | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Choate, Hall & Stewart LLP
Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Choate, Hall & Stewart LLP provides legal services. It offers services in the areas of private equity, technology, intellectual property, mergers & acquisitions, commercial litigation, and insurance & reinsurance litigation. The company was founded in 1899 and is headquartered in Boston, MA. | Commercial Services |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Palmer & Dodge LLP | Commercial Services |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Gerald Quirk
- Experience